Skip to main content

Together we are beating cancer

Donate now

Cancer News

Tim Bodicoat

Tim Bodicoat is a Science Writer for Cancer Research Horizons
Showing 2 out of 2 results
Minding the gap

Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up… Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up…

by Tim Bodicoat | Analysis | 3 February 2026

3 February 2026

This entry is part 1 of 1 in the series Minding the gap

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

by Tim Bodicoat | Interview | 26 April 2023

26 April 2023